Vitamin D Assays: Past And Present Debates, Difficulties, And Developments
W. Fraser, A. M. Milan
Published 2012 · Chemistry, Medicine
Download PDFAnalyze on Scholarcy
Clinical interest in Vitamin D and its purported roles not only in calcium and bone metabolism but in several other medical conditions (diabetes, cardiovascular disease, multiple sclerosis, cancer, psychiatric disorders, neuro-muscular disease) has led to a surge in laboratory requests for 25 hydroxy vitamin D and 1,25 dihydroxy vitamin D measurement. Circulating 25 hydroxy vitamin D concentration is routinely used as the best indicator of vitamin D status, but measurement of other metabolites, especially the physiologically active 1,25 dihyroxy vitamin D, are of clinical value. Over the last 40 years the development of assays for vitamin D and its metabolites from early competitive binding assays through to immunoassay and liquid chromatography aligned to mass spectrometry have demonstrated various analytical challenges, the advantages and disadvantages of each method are constantly changing with new technological developments. Immunoassay remains the predominant mode of measurement for 25-hydroxy vitamin D although problems with equimolar recovery of the D2 and D3 metabolites remain an issue. Standardisation of all assays has been improved but not resolved with the currently available reference materials as evidenced by the international vitamin D external quality assurance scheme, DEQAS. The choice of method for each laboratory remains a balance mainly between turn around time, convenience, cost and the specificity and accuracy of the information obtained. With increasing discussion and clinical interest surrounding other vitamin D metabolites the vitamin D assay debate is set to continue.
This paper references
Characterization of vitamin D3 metabolites using continuous-flow fast atom bombardment tandem mass spectrometry and high-performance liquid chromatography.
B. Yeung (1993)
Development of a candidate reference measurement procedure for the determination of 25-hydroxyvitamin D3 and 25-hydroxyvitamin D2 in human serum using isotope-dilution liquid chromatography-tandem mass spectrometry.
S. Tai (2010)
High-performance liquid chromatographic assay for 25-hydroxyvitamin D 3 in serum
Tj Gilbertson (1977)
Analytical evaluation of the new Abbott Architect 25-OH vitamin D assay.
E. Cavalier (2012)
Measurement of 25-hydroxyvitamin D3 (25OHD3) and 25-hydroxyvitamin D2 (25OHD2) in human serum using liquid chromatography-tandem mass spectrometry and its comparison to a radioimmunoassay method.
H. Chen (2008)
Current status of clinical 25-hydroxyvitamin D measurement: an assessment of between-laboratory agreement.
N. Binkley (2010)
Analytical and clinical validation of a radioimmunoassay for the measurement of 1,25 dihydroxy vitamin D.
Diana R Clive (2002)
Measurement of 25-hydroxyvitamin D3 in serum.
R. Bouillon (1976)
Quantification of 1α,25-dihydroxy vitamin D by immunoextraction and liquid chromatography-tandem mass spectrometry.
Frederick G. Strathmann (2011)
A radioimmunoassay for 1,25-dihydroxycholecalciferol.
T. Clemens (1978)
Serum vitamin D 2 and vitamin D 3 metabolite concentrations and absorption of vitamin D 2 in elderly subjects
Tl Clemens (1986)
Isotope dilution ultra performance liquid chromatography-tandem mass spectrometry method for simultaneous measurement of 25-hydroxyvitamin D2, 25-hydroxyvitamin D3 and 3-epi-25-hydroxyvitamin D3 in human serum.
R. Schleicher (2011)
Comparison of commercially available (125)I-based RIA methods for the determination of circulating 25-hydroxyvitamin D.
B. Hollis (2000)
Evaluation of 25-hydroxy vitamin D assay on the immunodiagnostic systems iSYS analyser
Zee N Cluse (2012)
A radioimmunoassay for 1,25-dihydroxycholecalciferol.
R. Bouillon (1980)
Development of a Method for the Quantification of 1α,25(OH)2–Vitamin D3 in Serum by Liquid Chromatography Tandem Mass Spectrometry without Derivatization
B. Casetta (2010)
Assay of 1,25-dihydroxy vitamin D3 by isotope dilution--mass fragmentography.
I. Björkhem (1979)
A competitive protein-binding assay for 25-hydroxycholecalciferol and 25-hydroxyergocalciferol in serum.
M. Preece (1974)
Radioreceptor assay for 1 alpha,25-dihydroxyvitamin D3.
P. Brumbaugh (1974)
1,25-Dihydroxyvitamin D3-26,23-lactone interferes in determination of 1,25-dihydroxyvitamin D by RIA after immunoextraction.
B. Hollis (1995)
Intestinal cholecalciferol absorption in the elderly and in younger adults.
J. Barragry (1978)
Measurement of circulating vitamin D in man.
T. Clemens (1982)
Extrarenal Expression of 25-Hydroxyvitamin D 3-1 a-Hydroxylase *
Daniel Zehnder (2001)
Accuracy of 6 Routine 25-Hydroxyvitamin D Assays: Influence of Vitamin D Binding Protein Concentration
M. Bissell (2013)
Development and certification of a standard reference material for vitamin D metabolites in human serum.
K. Phinney (2012)
Routine isotopedilution liquid chromatography-tandem mass spectrometry assay for simultaneous measurement of the 25-hydroxy metabolites of vitamins D 2 and D 3
Z Maunsell (2005)
Determination of 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 in human plasma using high-pressure liquid chromatography.
J. Eisman (1977)
Extrarenal Expression of 25-Hydroxyvitamin D3-1α-Hydroxylase1
D. Zehnder (2001)
Increasing liquid chromatography-tandem mass spectrometry throughput by mass tagging: a sample-multiplexed high-throughput assay for 25-hydroxyvitamin D2 and D3.
Brian C. Netzel (2011)
Plasma concentrations of vitamin D3 and its metabolites in the rat as influenced by vitamin D3 or 25-hydroxyvitamin D3 intakes.
R. Shephard (1980)
Sensitive measurement of serum 1α,25-dihydroxyvitamin D by liquid chromatography/tandem mass spectrometry after removing interference with immunoaffinity extraction.
C. Yuan (2011)
A modified radioimmunoassay for 1,25-dihydroxycholecalciferol.
T. Gray (1981)
Underestimation of serum 25-hydroxyvitamin D by the Nichols Advantage Assay in patients receiving vitamin D replacement therapy.
P. Leventis (2005)
Development and optimization of simplified LC-MS/MS quantification of 25-hydroxyvitamin D using protein precipitation combined with on-line solid phase extraction (SPE).
D. Thibeault (2012)
Pharmacokinetics of vitamin D toxicity.
G. Jones (2008)
Candidate reference measurement procedures for serum 25-hydroxyvitamin D3 and 25-hydroxyvitamin D2 by using isotope-dilution liquid chromatography-tandem mass spectrometry.
H. Stepman (2011)
Sensitive analysis of 1alpha,25-dihydroxyvitamin D3 in biological fluids by liquid chromatography-tandem mass spectrometry.
A. Kissmeyer (2001)
Determination of 25-hydroxyvitamin D in human plasma using high-performance liquid chromatography--tandem mass spectrometry.
N. Tsugawa (2005)
Determination of vitamin D status by radioimmunoassay with an 125I-labeled tracer.
B. Hollis (1993)
Effect of a 300 000-IU loading dose of ergocalciferol (Vitamin D2) on circulating 1,25(OH)2-vitamin D and fibroblast growth factor-23 (FGF-23) in vitamin D insufficiency.
C. Turner (2013)
Improved radioimmunoassay for vitamin D and its use in assessing vitamin D status.
B. W. Hollis (1985)
I-based RIA methods for the determination of circulating 25-hydroxyvitamin D
Quantification of 1a,25-dihydroxy vitamin D by immunoextraction and liquid chromatography-tandem mass spectrometry
Fg Strathmann (2011)
C-3 epimers can account for a significant proportion of total circulating 25-hydroxyvitamin D in infants, complicating accurate measurement and interpretation of vitamin D status.
R. Singh (2006)
Circulating 25-hydroxyvitamin D in man.
J. Haddad (1974)
Ultrasensitive quantification of serum vitamin D metabolites using selective solid-phase extraction coupled to microflow liquid chromatography and isotope-dilution mass spectrometry.
X. Duan (2010)
Structure-function relationships in the vitamin D endocrine system.
R. Bouillon (1995)
Clinical applications for vitamin D assays: what is known and what is wished for.
M. Kleerekoper (2011)
Misleading measures in Vitamin D analysis: A novel LC-MS/MS assay to account for epimers and isobars
Iltaf Shah (2011)
Competitive protein-binding radioassay for 25-hydroxycholecalciferol.
J. Haddad (1971)
RADIOIMMUNOASSAY OF 1,25‐DIHYDROXY VITAMIN D2: STUDIES ON THE METABOLISM OF VITAMIN D2 IN MAN
L. Fraher (1983)
High-performance liquid chromatographic assay for 25-hydroxyvitamin D3 in serum.
T. Gilbertson (1977)
Human anti-animal interference in DiaSorin Liaison total 25(OH)-vitamin D assay: towards the end of a strange story?
Etienne Cavalier (2012)
COMPETITIVE PROTEIN-BINDING RADIOASSAY FOR 25-HYDROXYCHOLECALCIFEROL1
J. Haddad (1971)
Serum vitamin D2 and vitamin D3 metabolite concentrations and absorption of vitamin D2 in elderly subjects.
T. Clemens (1986)
Candidate reference method for the quantification of circulating 25-hydroxyvitamin D3 by liquid chromatography-tandem mass spectrometry.
M. Vogeser (2004)
Issues of methodology, standardization and metabolite recognition for 25-hydroxyvitamin D when comparing the DiaSorin radioimmunoassay and the Nichols Advantage automated chemiluminescence protein-binding assay in hip fracture cases
P. Glendenning (2003)
How accurate are assays for 25-hydroxyvitamin D? Data from the international vitamin D external quality assessment scheme.
G. Carter (2004)
Metabolic profiling of major vitamin D metabolites using Diels–Alder derivatization and ultra-performance liquid chromatography–tandem mass spectrometry
P. Aronov (2008)
Assay of Vitamins D 2 and D 3 , and 25-Hydroxyvitamins D 2 and D 3 in Human Plasma by High-Performance Liquid Chromatography
Uskokovic MR (1980) A radioimmunoassay for 1,25-dihydroxycholecalciferol
R Bouillon (1980)
Proficiency testing of 25-Hydroxyvitamin D (25-OHD) assays
G. D. Carter (2010)
Ion suppression in the determination of clenbuterol in urine by solid-phase extraction atmospheric pressure chemical ionisation ion-trap mass spectrometry.
M. V. van Hout (2003)
State-oftheArt oftheArt oftheArt theArt theArt Vitamin D Assays : A Comparison of Automated Immunoassays with Liquid Chromatography – Tandem Mass Spectrometry Methods
Christopher-John L Farrell (2012)
Analytical and clinical validation of the 25 OH vitamin D assay for the LIAISON automated analyzer.
D. Ersfeld (2004)
Metabolism and excretion of 3H-1,25-(OH)2-vitamin D3 in healthy adults.
R. Gray (1978)
Current assays overestimate 25-hydroxyvitamin D3 and underestimate 25-hydroxyvitamin D2 compared with HPLC: need for assay-specific decision limits and metabolite-specific assays
P. Glendenning (2006)
Improved methodology for the analysis of plasma vitamin D metabolites.
R. Horst (1990)
Specific estimation of 24,25-dihydroxyvitamin D in plasma by gas chromatography-mass spectrometry.
R. D. Coldwell (1984)
On-line post-column Diels-Alder derivatization for the determination of vitamin D3 and its metabolites by liquid chromatography/thermospray mass spectrometry.
R. Vreeken (1993)
25-hydroxyvitamin D: a difficult analyte.
G. Carter (2012)
25-hydroxyvitamin D measurement, 2009: a review for clinicians.
N. Binkley (2009)
Standardization of vitamin D assays: art or science?
W. Fraser (2009)
Radioreceptor Assay for 1α,25-Dihydroxyvitamin D3
P. Brumbaugh (1974)
Development and validation of a liquid chromatography-tandem mass spectrometry assay for serum 25-hydroxyvitamin D2/D3 using a turbulent flow online extraction technology
Dustin R. Bunch (2009)
The effect of renal function on changes in circulating concentrations of 1,25-dihydroxycholecalciferol after an oral dose.
S. Papapoulos (1982)
Use of a common standard improves the performance of liquid chromatography-tandem mass spectrometry methods for serum 25-hydroxyvitamin-D
G. Carter (2009)
Serum 25-hydroxyvitamin D measurement in a large population survey with statistical harmonization of assay variation to an international standard.
E. Hyppönen (2007)
Comparison of commercially available 125
Bw Hollis (2000)
A microassay for 1,25-dihydroxyvitamin D not requiring high performance liquid chromatography: application to clinical studies.
T. Reinhardt (1984)
Competitive binding assay for vitamin D and 25-OH vitamin D.
R. Belsey (1971)
The C-3 epimer of 25-hydroxyvitamin D(3) is present in adult serum.
G. Lensmeyer (2012)
HPLC method for 25-hydroxyvitamin D measurement: comparison with contemporary assays.
G. Lensmeyer (2006)
Measurement of Plasma 1,25 Dihydroxyvitamin D Using a Novel Immunoextraction Technique and Immunoassay with Iodine Labelled Vitamin D Tracer
W. Fraser (1997)
Routine isotope-dilution liquid chromatography-tandem mass spectrometry assay for simultaneous measurement of the 25-hydroxy metabolites of vitamins D2 and D3.
Z. Maunsell (2005)
Measurement of Plasma 25‐Hydroxycholecalciferol in Man
F. Bayard (1972)
Assay of vitamins D2 and D3, and 25-hydroxyvitamins D2 and D3 in human plasma by high-performance liquid chromatography.
G. Jones (1978)
Low circulating vitamin D in obesity
Y. Liel (2007)
Quantification of circulating 1,25-dihydroxyvitamin D by radioimmunoassay with 125I-labeled tracer.
B. Hollis (1996)
A simple automated solid-phase extraction procedure for measurement of 25-hydroxyvitamin D3 and D2 by liquid chromatography-tandem mass spectrometry
S. Knox (2009)
NHANES monitoring of serum 25-hydroxyvitamin D: a roundtable summary.
E. Yetley (2010)
Vitamin D Metabolites and Calcium Absorption in Severe Vitamin D Deficiency
A. Need (2008)
Acute effects of intravenous 1 alpha-hydroxycholecalciferol on parathyroid hormone, osteocalcin and calcitriol in man.
S. Gallacher (1994)
Importance of the isolation of 25-hydroxyvitamin D before assay.
L. Dorantes (1978)
Characterization of vitamin D 3 metabolites using continuous-flow fast atom bombardment tandem mass spectrometry and high-performance liquid chromatography
B Yeung (1993)
Evaluation of a 1,25-dihydroxyvitamin D enzyme immunoassay.
I. Seiden-Long (2007)
Sensitive analysis of 1α,25-dihydroxyvitamin D3 in biological fluids by liquid chromatography–tandem mass spectrometry
A. Kissmeyer (2001)
Competitive protein-binding assay for 25-hydroxycholecalciferol.
S. Edelstein (1974)
This paper is referenced by
Vitamin D Measurements — Facts and Fancies
Tar Choon Aw (2013)
Subclinical and asymptomatic parathyroid disease: implications of emerging data.
D. Macfarlane (2013)
Vitamin D metabolite quantitation by LC-MS/MS
Hemamalini Ketha (2017)
Vitamin D supplementation has no effects on progression of motor dysfunction in amyotrophic lateral sclerosis (ALS)
F. Trojsi (2019)
Wpływ witaminy D3 na kruchość kulinarnego mięsa wołowego
U. Rafalska (2014)
The effect of 14 weeks of vitamin D3 supplementation on antimicrobial peptides and proteins in athletes
Cheng-Shiun He (2016)
Vitamin D and Bone Health: A Practical Clinical Guideline for Patient Management
V I T (2013)
Development of an assay for vitamin D in biological samples
Abu Baker Kassim (2018)
Vitamin D and systemic lupus erythematosus: an update
C. C. Mok (2013)
The prevalence and determinants of adequate vitamin D intake and supplementation among Canadian children
Dona Ll. Munasinghe (2016)
Milk fortified with vitamin D could reduce the prevalence of vitamin D deficiency among Japanese female college students
Y. Suzuki (2014)
Magnesium Supplementation in Vitamin D Deficiency
P. Reddy (2019)
Vitamin D in Fetal Development: Findings From a Birth Cohort Study
P. Hart (2015)
Intensive Care and Vitamin D Status
Dima A. Youssef (2014)
Vitamin D Testing in Clinical Settings: Methodologies, Accuracy and Standardization
Fakhri B Saida (2018)
Effects of Iron on Vitamin D Metabolism: A Systematic Review
Fatemeh Azizi-soleiman (2016)
Automated measurement of 25-OH Vitamin D on the LUMIPULSE® G1200: analytical verification and method comparison
Marina Parra (2016)
Evaluation of the 25-hydroxy vitamin D assay on a fully automated liquid chromatography mass spectrometry system, the Thermo Scientific Cascadion SM Clinical Analyzer with the Cascadion 25-hydroxy vitamin D assay in a routine clinical laboratory
Sally C Benton (2019)
Impact of Vitamin D Supplementation on Arterial Vasomotion, Stiffness and Endothelial Biomarkers in Chronic Kidney Disease Patients
N. Chitalia (2014)
Correlation of low serum vitamin-D with uterine leiomyoma: a systematic review and meta-analysis
Ramin Mohammadi (2020)
Prevalence and Predictors of Low Serum 25-Hydroxyvitamin D among Female African-American Breast Cancer Survivors.
P. Sheean (2018)
Management of endocrine disease: value and limitations of assessing vitamin D nutritional status and advised levels of vitamin D supplementation.
E. Romagnoli (2013)
Screening for Vitamin D Deficiency: A Systematic Review for the U.S. Preventive Services Task Force
E. LeBlanc (2015)
Serum free and bio-available 25-hydroxyvitamin D correlate better with bone density than serum total 25-hydroxyvitamin D
M. S. Johnsen (2014)
Older Swedish Adults with High Self-Perceived Health Show Optimal 25-Hydroxyvitamin D Levels Whereas Vitamin D Status Is Low in Patients with High Disease Burden
M. Carlsson (2016)
Prevalence of 25-hydroxyvitamin D₂ in Western New York: a 3-year study.
Yan Victoria Zhang (2015)
Vitamin D and exercise performance : influence of simulated sunlight and oral supplementation
Alexander T. Carswell (2019)
A importância clínica da vitamina D
Tânia Marisa Macedo Pinheiro (2015)
Social Disadvantage Is Associated With Lower Vitamin D Levels in Older People and There Is No Surrogate for Its Measurement
A. Heald (2017)
Vitamin D in the Prevention and Treatment of Osteoarthritis: From Clinical Interventions to Cellular Evidence
Clara Yongjoo Park (2019)
A High Throughput Universal Vitamin D Assay for Automated Chemistry Analyzers
Saida Fb (2019)
Critical evaluation of assays for vitamin D status
F. G. Lorencio (2013)See more